Drugs

Drugs in Development for Hepatitis B
pp. 1451-1460(10)
Authors: Buti, Maria; Esteban, Rafael

Antifungal Combination Therapy: Clinical Potential
pp. 1461-1480(20)
Authors: Baddley, John W.; Pappas, Peter G.

Drug Treatment of Haemorrhoids
pp. 1481-1491(11)
Authors: Misra, Mahesh C.; Imlitemsu,

Immunological Aetiology of Major Psychiatric Disorders: Evidence and Therapeutic Implications
pp. 1493-1520(28)
Author: Sperner-Unterweger, Barbara

Impact of Smoking on Asthma Therapy: A Critical Review of Clinical Evidence
pp. 1521-1536(16)
Authors: Livingston, Eric; Thomson, Neil C.; Chalmers, George W.

Pharmacological Management of Nasal Polyposis
pp. 1537-1552(16)
Authors: Bachert, Claus; Watelet, Jean-Baptiste; Gevaert, Philippe; Paul Van Cauwenberge,

Posaconazole
pp. 1553-1567(15)
Author: Keating, Gillian M.

Posaconazole: A Viewpoint by Oliver A. Cornely
pp. 1568-1569(2)
Author: Cornely, Oliver A.

Posaconazole: A Viewpoint by John R. Perfect
pp. 1568-1569(2)
Author: Perfect, John R.

Pegaptanib: In Exudative Age-Related Macular Degeneration
pp. 1571-1577(7)
Authors: Siddiqui, M. Asif A.; Keating, Gillian M.

Pegaptanib in Exudative Age-Related Macular Degeneration: A Viewpoint by Steven Schwartz
pp. 1578-1579(2)
Author: Schwartz, Steven

Pegaptanib in Exudative Age-Related Macular Degeneration: A Viewpoint by Winfried M. Amoaku
pp. 1578-1579(2)
Author: Amoaku, Winfried M.

Rosiglitazone/Metformin
pp. 1581-1592(12)
Author: Wellington, Keri

Rosiglitazone/Metformin: A Viewpoint by William L. Isley
pp. 1593-1594(2)
Author: Isley, William L.

Rosiglitazone/Metformin: A Viewpoint by Giulio Marchesini
pp. 1593-1594(2)
Author: Marchesini, Giulio